Literature DB >> 21852522

Screening for novel quorum-sensing inhibitors to interfere with the formation of Pseudomonas aeruginosa biofilm.

Xian Ding1,2, Bo Yin3, Li Qian4, Zhirui Zeng2, Zeliang Yang2, Huixian Li2, Yongjun Lu2, Shining Zhou2.   

Abstract

The objective of this study was to screen for novel quorum-sensing inhibitors (QSIs) from traditional Chinese medicines (TCMs) that inhibit bacterial biofilm formation. Six of 46 active components found in TCMs were identified as putative QSIs based on molecular docking studies. Of these, three compounds inhibited biofilm formation by Pseudomonas aeruginosa and Stenotrophomonas maltophilia at a concentration of 200 µM. A fourth compound (emodin) significantly inhibited biofilm formation at 20 µM and induced proteolysis of the quorum-sensing signal receptor TraR in Escherichia coli at a concentration of 3-30 mM. Emodin also increased the activity of ampicillin against P. aeruginosa. Therefore, emodin might be suitable for development into an antivirulence and antibacterial agent.
© 2011 SGM

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21852522     DOI: 10.1099/jmm.0.024166-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  32 in total

Review 1.  Role of quorum sensing in bacterial infections.

Authors:  Israel Castillo-Juárez; Toshinari Maeda; Edna Ayerim Mandujano-Tinoco; María Tomás; Berenice Pérez-Eretza; Silvia Julieta García-Contreras; Thomas K Wood; Rodolfo García-Contreras
Journal:  World J Clin Cases       Date:  2015-07-16       Impact factor: 1.337

Review 2.  Exploiting quorum sensing to confuse bacterial pathogens.

Authors:  Breah LaSarre; Michael J Federle
Journal:  Microbiol Mol Biol Rev       Date:  2013-03       Impact factor: 11.056

3.  Thromboresistant/anti-biofilm catheters via electrochemically modulated nitric oxide release.

Authors:  Hang Ren; Alessandro Colletta; Dipankar Koley; Jianfeng Wu; Chuanwu Xi; Terry C Major; Robert H Bartlett; Mark E Meyerhoff
Journal:  Bioelectrochemistry       Date:  2014-12-18       Impact factor: 5.373

4.  Anti-quorum sensing potential of ketoprofen and its derivatives against Pseudomonas aeruginosa: insights to in silico and in vitro studies.

Authors:  Amineh Sadat Tajani; Elham Jangi; Maryam Davodi; Sima Golmakaniyoon; Razieh Ghodsi; Vahid Soheili; Bibi Sedigheh Fazly Bazzaz
Journal:  Arch Microbiol       Date:  2021-07-28       Impact factor: 2.552

5.  Computational and Biological Evaluation of β-Adrenoreceptor Blockers as Promising Bacterial Anti-Virulence Agents.

Authors:  Ahmad J Almalki; Tarek S Ibrahim; Sameh S Elhady; Wael A H Hegazy; Khaled M Darwish
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-18

6.  Effect of Cyclodextrins on the Biofilm Formation Capacity of Pseudomonas aeruginosa PAO1.

Authors:  Zsófia Berkl; Ildikó Fekete-Kertész; Kata Buda; Emese Vaszita; Éva Fenyvesi; Lajos Szente; Mónika Molnár
Journal:  Molecules       Date:  2022-06-03       Impact factor: 4.927

7.  Anti-quorum sensing potential of the mangrove Rhizophora annamalayana.

Authors:  Khadar Syed Musthafa; Sunil Kumar Sahu; Arumugam Veera Ravi; Kandasamy Kathiresan
Journal:  World J Microbiol Biotechnol       Date:  2013-04-17       Impact factor: 3.312

8.  Antibacterial Flavonoids from Medicinal Plants Covalently Inactivate Type III Protein Secretion Substrates.

Authors:  Lun K Tsou; María Lara-Tejero; Jordan RoseFigura; Zhenrun J Zhang; Yen-Chih Wang; Jacob S Yount; Matthew Lefebre; Paul D Dossa; Junya Kato; Fulan Guan; Wing Lam; Yung-Chi Cheng; Jorge E Galán; Howard C Hang
Journal:  J Am Chem Soc       Date:  2016-02-16       Impact factor: 15.419

9.  Shikonin Induces Apoptosis, Necrosis, and Premature Senescence of Human A549 Lung Cancer Cells through Upregulation of p53 Expression.

Authors:  Yueh-Chiao Yeh; Tsun-Jui Liu; Hui-Chin Lai
Journal:  Evid Based Complement Alternat Med       Date:  2015-02-09       Impact factor: 2.629

10.  Advances in the Microbiology of Stenotrophomonas maltophilia.

Authors:  Joanna S Brooke
Journal:  Clin Microbiol Rev       Date:  2021-05-26       Impact factor: 50.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.